Latest EU Pharma Reform Proposals Risk Stifling Innovation And Competitiveness

 
• By Ian Schofield

EU policymakers have the chance to adopt legislation that establishes a strong and predictable framework of incentives for R&D into new medicines, particularly those that require riskier investments, says CSL Behring’s Lutz Bonacker.

Cardboard box with question mark - Concept of mystery box
Stakeholders have many questions about the EU pharma reform package • Source: Shutterstock

More from Europe

More from Geography